Atlas Trials

Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)

Clinical trial NCT07288814 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07288814
Sponsor
Sun Yat-Sen University Cancer Center
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed or Refractory Peripheral T Cell Lymphoma
Start date
2025-12-08
Primary completion
2026-12-31
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.